The EDP (see Epoxydocosapentaenoic acid) and EEQ (see epoxyeicosatetraenoic acid) metabolites have a broad range of activities. In various animal models and in vitro studies on animal and human tissues, they decrease hypertension and pain perception; suppress inflammation; inhibit angiogenesis, endothelial cell migration and endothelial cell proliferation; and inhibit the growth and metastasis of human breast and prostate cancer cell lines.
The EDP (see Epoxydocosapentaenoic acid) and EEQ (see epoxyeicosatetraenoic acid) metabolites demonstrate a broad spectrum of activities in various animal models and in vitro studies on both animal and human tissues, including lowering blood pressure, reducing pain perception, suppressing inflammation, inhibiting angiogenesis, endothelial cell migration and proliferation, and hindering the growth and metastasis of human breast and prostate cancer cells.